An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.
about
Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responsesOrigination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune systemMolecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.B7-H3 overexpression in pancreatic cancer promotes tumor progression.Inhibitors of B7-CD28 costimulation in urologic malignancies.B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcomeT cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets.B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeDifferent expression of B7-H3 in the caput, corpus, and cauda of the epididymis in mouseAntitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo.The contrasting role of B7-H3.Fine tuning the immune response through B7-H3 and B7-H4Clinical importance of B7-H3 expression in human pancreatic cancer.B7-H3-mediated tumor immunology: Friend or foe?The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.Upregulation of the B7/CD28 family member B7-H3 in bladder cancer.
P2860
Q24316331-A062166C-F099-4362-BF07-0DA30E581DEFQ28740426-2A75E66F-E712-42BB-BC90-4A56FED5B502Q33628125-669A8D0A-FE31-4127-98CD-BCC80D4F3429Q33703916-546A3528-D5A3-49CD-BE0A-28A5CBF55F6DQ33827752-D392AB7A-C05B-4EBC-B01B-B8479E248EB9Q34105913-6183C8A2-FF8A-43D2-B618-3BD6349B5C1BQ34577158-0CE7831C-01FB-40F7-BED4-17C80E4A96BEQ35660891-F65B7FC2-2D75-4DA8-A248-17786882DCFBQ36288654-51D51DAA-A211-43A0-AE4F-8046779906EAQ36334683-F1BA2E71-CAB7-440C-A1DC-F1981C371E04Q36358601-278FA2F6-8FDE-4CBB-BCB1-CFCBAF6072DFQ36802534-698143C0-B20A-4A15-B3CC-8C34EA0F6155Q37227080-944A9ED0-3553-4321-992F-D40CFDF7E9D2Q37424100-83298C24-8486-4C8F-8C90-A89EA9F7C275Q38135281-3C77D1D4-6703-4F6E-929A-BBA5CAA226CAQ39160982-F7D50168-71F9-4978-B6DE-0B153CBD78DAQ39742066-E6A21150-263B-4707-9A51-01AC736657B2Q39768670-4E0DE0C7-5CDB-49A6-8E2B-903CC30D608BQ41851335-2664FA3A-4F0E-49EB-85BC-E3F5F67570F1
P2860
An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.
@en
type
label
An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.
@en
prefLabel
An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.
@en
P2093
P2860
P356
P1476
An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo
@en
P2093
Alaviana D Lupu
Catalin M Lupu
Christoph Eisenbach
Jan Schmidt
Jens Encke
Michael A Kuefner
P2860
P2888
P304
P356
10.1007/BF03239969
P50
P577
2006-05-01T00:00:00Z